ELAN - Elanco Animal Health Incorporated

NYSE - NYSE Delayed Price. Currency in USD

Elanco Animal Health Incorporated

2500 Innovation Way
Greenfield, IN 46140
United States

IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees5,800

Key Executives

NameTitlePayExercisedYear Born
Mr. Jeffrey N. SimmonsPres, CEO & Director1.73MN/A1967
Mr. Todd S. YoungExec. VP & CFO379.52kN/A1972
Mr. David S. KinardExec. VP of HR626.41kN/A1967
Ms. Sarena S. LinExec. VP of Elanco USA, Corp. Strategy & Global Marketing1.52MN/A1971
Mr. David Alan UrbanekExec. VP of Manufacturing & Quality637.88kN/A1966
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Elanco Animal Health Incorporated, an animal health company, develops, manufactures, and markets products for companion and food animals. The company offers companion animal disease prevention products, such as parasiticide products that protect pets from worms, fleas, and ticks; companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications; vaccines, nutritional enzymes, and animal-only antibiotics; and a range of food animal products used in ruminant and swine production. It sells its products to third-party distributors; veterinarians; and food animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. Elanco Animal Health Incorporated has a research and development collaboration with AgBiome, Inc. to develop nutritional health products for swine. The company was founded in 1954 and is headquartered in Greenfield, Indiana. Elanco Animal Health Incorporated is a subsidiary of Eli Lilly and Company.

Corporate Governance

Elanco Animal Health Incorporated’s ISS Governance QualityScore as of July 29, 2019 is 7. The pillar scores are Audit: 2; Board: 9; Shareholder Rights: 8; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.